Evolus (EOLS) EBITDA Margin (2019 - 2026)
Evolus (EOLS) posted EBITDA Margin of 9.36% for Q1 2026, down 300.36% on a QoQ basis from 4.67% in Q4 2025, and up 1278.0% year-over-year from 0.68% in Q1 2025.
Evolus (EOLS) EBITDA Margin (2019 - 2026) Analysis & Trends
Evolus' EBITDA Margin history runs 8 years deep, the most recent figure standing at 9.36% for Q1 2026.
- Quarterly EBITDA Margin rose 1278.0% year-over-year to 9.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.06% (up 670.0% YoY) and the FY2025 annual result came in at 10.99%, up 193.0% from the prior year.
- EBITDA Margin was 9.36% for Q1 2026 at Evolus, down from 4.67% in the prior quarter.
- Across five years, EBITDA Margin topped out at 4.67% in Q4 2025 and bottomed at 57.44% in Q2 2022.
- A 5-year average of 23.16% and a median of 22.14% in 2025 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 2765 bps in 2022, while the deepest fall reached 11113 bps in 2022.
- Evolus' EBITDA Margin stood at 24.37% in 2022, then jumped by 42 bps to 14.16% in 2023, then soared by 79 bps to 2.93% in 2024, then soared by 259 bps to 4.67% in 2025, then tumbled by 300 bps to 9.36% in 2026.
- Business Quant data shows EOLS's EBITDA Margin at 9.36% in Q1 2026, 4.67% in Q4 2025, and 16.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -9.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.36% |
| Dec 31, 2025 | 4.67% |
| Sep 30, 2025 | -16.67% |
| Jun 30, 2025 | -14.71% |
| Mar 31, 2025 | -22.14% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | -25.33% |
| Jun 30, 2024 | -11.51% |
| Mar 31, 2024 | -15.04% |
| Dec 31, 2023 | -14.16% |
| Sep 30, 2023 | -26.87% |
| Jun 30, 2023 | -30.64% |
| Mar 31, 2023 | -28.86% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | -52.80% |
| Jun 30, 2022 | -57.44% |
| Mar 31, 2022 | -45.56% |
| Dec 31, 2021 | -52.02% |
| Sep 30, 2021 | -71.63% |
| Jun 30, 2021 | -58.60% |